Related references
Note: Only part of the references are listed.Association of serum calcium and phosphorus with measures of left ventricular structure and function: The ARIC study
Kripa Poudel et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Elevated Fibroblast Growth Factor 23 and Decreased Klotho Levels Are Associated With Diastolic Dysfunction in CKD G4- 5D Patients
Ludmila Yu Milovanova et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD
Shilpa Sharma et al.
KIDNEY INTERNATIONAL REPORTS (2019)
Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Charles Ginsberg et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease
Jose Tunon et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study
Amber L. Fyfe-Johnson et al.
JOURNAL OF HYPERTENSION (2016)
Residual Kidney Function Decline and Mortality in Incident Hemodialysis. Patients
Yoshitsugu Obi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population
Maria Bozentowicz-Wikarek et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2016)
Preservation of residual kidney function in hemodialysis patients: reviving an old concept
Anna T. Mathew et al.
KIDNEY INTERNATIONAL (2016)
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis
Julia J. Scialla et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Alexander Grabner et al.
CELL METABOLISM (2015)
Diastolic Dysfunction Is an Independent Predictor of Cardiovascular Events in Incident Dialysis Patients with Preserved Systolic Function
Jae Hyun Han et al.
PLOS ONE (2015)
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease
Myles Wolf et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
FGF23 regulates renal sodium handling and blood pressure
Olena Andrukhova et al.
EMBO MOLECULAR MEDICINE (2014)
Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
Anna Jovanovich et al.
ATHEROSCLEROSIS (2013)
Determinants of Progression of Aortic Stiffness in Hemodialysis Patients: A Prospective Longitudinal Study
Mihai S. Utescu et al.
HYPERTENSION (2013)
Elevated E/E' Predicts Cardiovascular Events in Hemodialysis Patients with Preserved Systolic Function
Yuko Iwabuchi et al.
INTERNAL MEDICINE (2012)
Abdominal Aortic Calcification is Associated with Diastolic Dysfunction, Mortality, and Nonfatal Cardiovascular Events in Maintenance Hemodialysis Patients
Hye Eun Yoon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Myles Wolf
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Clinical relevance of FGF-23 in chronic kidney disease
Sarah Seiler et al.
KIDNEY INTERNATIONAL (2009)
Left ventricular diastolic dysfunction in normotensive diabetic patients in various age strata
Hisashi Masugata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)